DHA Soft Gel Capsule

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

docosahexaenoic acid (DHA)-rich oil derived from microalgae Schizochytrium sp., Quantity: 250 mg (Equivalent: docosahexaenoic acid, Qty 100 mg)

Available from:

Health Spring Australia

INN (International Name):

docosahexaenoic acid (DHA)-rich oil derived from microalgae Schizochytrium sp.

Pharmaceutical form:

Capsule, soft

Composition:

Excipient Ingredients: Gelatin; vanillin; vegetable oil; d-alpha-tocopherol; purified water; glycerol

Administration route:

Oral

Therapeutic indications:

Helps maintain/support healthy eye development ; Maintain/support healthy eye function ; Maintain/support eye health ; Helps enhance/promote general health and wellbeing ; Maintain/support general health and wellbeing ; Maintain/support cardiovascular system health ; Maintain/support brain function ; Maintain/support brain health ; Maintain/support nervous system health ; Maintain/support brain/central nervous system development ; Maintain/support nervous system function

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2016-01-13